Clinical Trial Update: Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating mesenchymal stromal cells for treating type 1 diabetes in children and adolescents and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Uppsala University Hospital | Conditions: Type1diabetes | Phase 1, Phase 2 | Status: RECRUITING